30 Programs
-
Optimizing the Integration of ADCs into the Treatment of HR-Positive and Triple-Negative Metastatic Breast Cancer
-
-
L
-
L
-
-
L
-
L
-
-
Current and Future Role of Molecular Residual Disease Analysis and Its Relevance in Colorectal Cancer
-
-
J
-
J
-
-
J
-
J
-
-
Current and Future Management of Extrapulmonary Neuroendocrine Carcinoma
-
-
J
-
J
-
-
J
-
J
-
-
Optimal Management of Brain Metastases in Patients with HER2-Positive Breast Cancer
-
-
S
-
S
-
-
S
-
S
-